| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 307.04B | 309.11B | 293.31B | 282.69B | 249.52B | 198.07B |
| Gross Profit | 38.50B | 38.85B | 34.23B | 34.48B | 28.23B | 18.46B |
| EBITDA | 32.44B | 32.33B | 28.91B | 30.69B | 25.28B | 15.70B |
| Net Income | 12.14B | 11.18B | 6.93B | 10.12B | 4.79B | -4.40B |
Balance Sheet | ||||||
| Total Assets | 341.15B | 343.73B | 333.19B | 318.84B | 300.29B | 279.42B |
| Cash, Cash Equivalents and Short-Term Investments | 28.12B | 31.80B | 29.92B | 28.29B | 27.99B | 29.28B |
| Total Debt | 74.41B | 74.74B | 62.73B | 70.91B | 74.82B | 74.23B |
| Total Liabilities | 148.30B | 154.18B | 156.21B | 158.12B | 156.56B | 147.70B |
| Stockholders Equity | 182.94B | 179.47B | 167.35B | 151.30B | 134.46B | 122.93B |
Cash Flow | ||||||
| Free Cash Flow | -480.00M | -6.68B | 15.09B | 9.68B | -92.00M | 3.05B |
| Operating Cash Flow | 18.67B | 13.89B | 29.16B | 26.00B | 16.79B | 14.90B |
| Investing Cash Flow | -16.10B | -22.53B | -13.72B | -17.43B | -15.86B | -12.16B |
| Financing Cash Flow | -1.82B | 7.65B | -14.90B | -8.59B | -2.86B | -1.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥1.01T | 25.08 | 9.10% | 1.63% | 9.80% | 13.15% | |
79 Outperform | ¥1.50T | 18.30 | ― | 2.18% | 3.25% | 1.71% | |
74 Outperform | ¥317.15B | 16.78 | 7.86% | 2.55% | 5.68% | 41.20% | |
66 Neutral | ¥86.56B | 7.19 | 6.66% | 3.36% | 1.87% | 86.87% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥137.95B | 25.57 | 2.64% | 2.30% | 0.90% | 15.74% | |
58 Neutral | ¥488.47B | 20.59 | 11.46% | 3.77% | 2.76% | 56.11% |